全文获取类型
收费全文 | 56247篇 |
免费 | 4706篇 |
国内免费 | 49篇 |
专业分类
61002篇 |
出版年
2023年 | 200篇 |
2022年 | 584篇 |
2021年 | 1004篇 |
2020年 | 556篇 |
2019年 | 741篇 |
2018年 | 1133篇 |
2017年 | 889篇 |
2016年 | 1566篇 |
2015年 | 2585篇 |
2014年 | 2875篇 |
2013年 | 3368篇 |
2012年 | 4342篇 |
2011年 | 4153篇 |
2010年 | 2637篇 |
2009年 | 2319篇 |
2008年 | 3337篇 |
2007年 | 3101篇 |
2006年 | 2833篇 |
2005年 | 2558篇 |
2004年 | 2502篇 |
2003年 | 2226篇 |
2002年 | 1897篇 |
2001年 | 1645篇 |
2000年 | 1536篇 |
1999年 | 1218篇 |
1998年 | 528篇 |
1997年 | 468篇 |
1996年 | 401篇 |
1995年 | 393篇 |
1994年 | 305篇 |
1993年 | 298篇 |
1992年 | 639篇 |
1991年 | 515篇 |
1990年 | 474篇 |
1989年 | 479篇 |
1988年 | 405篇 |
1987年 | 390篇 |
1986年 | 318篇 |
1985年 | 329篇 |
1984年 | 270篇 |
1983年 | 224篇 |
1982年 | 189篇 |
1981年 | 162篇 |
1980年 | 160篇 |
1979年 | 220篇 |
1978年 | 197篇 |
1977年 | 179篇 |
1976年 | 170篇 |
1974年 | 196篇 |
1972年 | 155篇 |
排序方式: 共有10000条查询结果,搜索用时 13 毫秒
931.
Glycoproteins in human serum play fundamental roles in many biological processes, and also have clinical value as biomarkers for disease progression and treatment. In this study, we isolated glycoproteins from the sera of three healthy individuals and three lung adenocarcinoma patients using multilectin affinity chromatography. The recovered glycoproteins were subjected to treatment with peptide-N-glycosidase F (PNGase F) and in-gel digestion by trypsin. Tryptic peptides were analyzed by nano-LC coupled to ESI-MS/MS and the MS/MS spectra were processed by Bioworks 3.2 and an in-house bioinformatics tool, ProtAn. Approximately 90% of the proteins identified contained more than one potential glycosylation site. Comparison of the serum glycoproteome of healthy and adenocarcinoma individuals revealed 38 cancer-selective proteins. Among them, 60% have previously been reported as low abundance proteins in human sera. We identified several cancer-selective proteins that have been previously characterized as potential indicators of lung cancer in serum or plasma, including haptoglobin (HP), inter-alpha-trypsin inhibitor heavy chain 4 (ITI-H4), complement C3 precursor, and leucine-rich alpha-2-glycoprotein. In addition, plasma kallikrein (KLKB1) and inter-alpha-trypsin inhibitor heavy chain 3 (ITI-H3) were identified as being potentially elevated in the lung cancer group, and were validated by Western blot analysis. Furthermore, approximately 18 kDa plasma kallirein protein fragment was detected at high levels in 25 out of 28 adenocarcinoma patients, while one of the eight normal individuals showed moderate positive. The results suggest that KLKB1 represents a potential candidate serum biomarker of lung cancer. 相似文献
932.
Song WS Kim HM Kim JH Sim SH Ryou SM Kim S Cha CJ Cunningham PR Bae J Lee K 《Journal of microbiology (Seoul, Korea)》2007,45(5):418-421
The nucleotide at position 791(G791) of E. coli 16S rRNA was previously identified as an invariant residue for ribosomal function. In order to characterize the functional role of G791, base substitutions were introduced at this position, and mutant ribosomes were analyzed with regard to their protein synthesis ability, via the use of a specialized ribosome system. These ribosomal RNA mutations attenuated the ability of ribosomes to conduct protein synthesis by more than 65%. A transition mutation (G to A) exerted a moderate effect on ribosomal function, whereas a transversion mutation (G to C or U) resulted in a loss of protein synthesis ability of more than 90%. The sucrose gradient profiles of ribosomes and primer extension analysis showed that the loss of protein-synthesis ability of mutant ribosomes harboring a base substitution from G to U at position 791 stems partially from its inability to form 70S ribosomes. These findings show the involvement of the nucleotide at position 791 in the association of ribosomal subunits and protein synthesis steps after 70S formation, as well as the possibility of using 16S rRNA mutated at position 791 for the selection of second-site revertants in order to identify ligands that interact with G791 in protein synthesis. 相似文献
933.
Lee EM Park HR Hwang JH Park DJ Chang KS Kim CJ 《Journal of microbiology and biotechnology》2007,17(11):1856-1861
Physiological cell conditions such as glucose deprivation and hypoxia play roles in the development of drug resistance in solid tumors. These tumor-specific conditions cause decreased expression of DNA topoisomerase IIalpha, rendering cells resistant to topo II target drugs such as etoposide. Thus, targeting tumor-specific conditions such as a low glucose environment may be a novel strategy in the development of anticancer drugs. On this basis, we established a novel screening program for anticancer agents with preferential cytotoxic activity in cancer cells under glucose-deprived conditions. We recently isolated an active compound, AA-98, from Streptomyces sp. AA030098 that can prevent stress-induced etoposide resistance in vitro. Furthermore, LC-MS and various NMR spectroscopic methods identified AA-98 as mithramycin, which belongs to the aureolic acid group of antitumor compounds. We found that mithramycin prevents the etoposide resistance that is induced by glucose deprivation. The etoposide-chemosensitive action of mithramycin was just dependent on strict low glucose conditions, and resulted in the selective cell death of etoposide-resistant HT-29 human colon cancer cells. 相似文献
934.
935.
Steven P. Govek Celine Bonnefous Jackaline D. Julien Johnny Y. Nagasawa Mehmet Kahraman Andiliy G. Lai Karensa L. Douglas Anna M. Aparicio Beatrice D. Darimont Katherine L. Grillot James D. Joseph Joshua A. Kaufman Kyoung-Jin Lee Nhin Lu Michael J. Moon Rene Y. Prudente John Sensintaffar Peter J. Rix Nicholas D. Smith 《Bioorganic & medicinal chemistry letters》2019,29(3):367-372
Potent estrogen receptor ligands typically contain a phenolic hydrogen-bond donor. The indazole of the selective estrogen receptor degrader (SERD) ARN-810 is believed to mimic this. Disclosed herein is the discovery of ARN-810 analogs which lack this hydrogen-bond donor. These SERDs induced tumor regression in a tamoxifen-resistant breast cancer xenograft, demonstrating that the indazole NH is not necessary for robust ER-modulation and anti-tumor activity. 相似文献
936.
937.
Lee Changsu Song Hye Seon Lee Se Hee Kim Joon Yong Rhee Jin-Kyu Roh Seong Woon 《Archives of microbiology》2021,203(1):261-268
Archives of Microbiology - Extremely halophilic archaea (haloarchaea) belonging to the phylum Euryarchaeota have been found in high-salinity environments. In this study, Halarchaeum sp. CBA1220,... 相似文献
938.
Bone marrow-derived mesenchymal stem cells (BMSCs) are of particular interest in the field of tissue engineering because of
their potential to differentiate into osteoblasts, chondrocytes, and neuronal cells. In order to promote the differentiation
of BMSCs into specific cell types, appropriate scaffold biomaterials and bioactive molecules that can support the differentiation
of BMSCs into specific cell types are needed. We hypothesized that β-mercaptoethanol (BME), which has been reported to induce
the differentiation of BMSCs into neural-like cells, promotes BMSCs to differentiate into neural-like cells when BME is added
to polymeric scaffolds containing the BMSCs. We fabricated biocompatible film shaped scaffolds composed of poly(lacti-co-glycolic)
acid (PLGA) and various concentrations of BME to confirm that BME-promoted differentiation of BMSCs is concentration-dependent.
Cell proliferation increased as the BME concentration in the films increased at the early stage, and the proliferation rate
remained similar on the PLGA films for 3 weeks following the BMSC seeding. The expression of neuronal markers in differentiated
BMSCs was assessed by RT-PCR. At 2- and 3-week time-points, mRNA expression of neurofilament and neuron specific enolase was
significantly increased in PLGA/BME films containing 400 μM BME compared to PLGA films. Thus, we have identified BMSC-seeded
PLGA/BME films with 200 μM and 400 μM BME as potentially useful candidates for neural tissue engineering applications by promoting
BMSC proliferation and differentiation towards neural-like cells. 相似文献
939.
The identification of true causal loci to unravel the statistical evidence of genotype-phenotype correlations and the biological
relevance of selected single-nucleotide polymorphisms (SNPs) is a challenging issue in genome-wide association studies (GWAS).
Here, we introduced a novel method for the prioritization of SNPs based on p-values from GWAS. The method uses functional evidence from populations, including phenotype-associated gene expressions. Based on
the concept of genetic interactions, such as perturbation of gene expression by genetic variation, phenotype and gene expression
related SNPs were prioritized by adjusting the p-values of SNPs. We applied our method to GWAS data related to drug-induced cytotoxicity. Then, we prioritized loci that potentially
play a role in druginduced cytotoxicity. By generating an interaction model, our approach allowed us not only to identify
causal loci, but also to find intermediate nodes that regulate the flow of information among causal loci, perturbed gene expression,
and resulting phenotypic variation. 相似文献
940.
Putcharoen O Lee SH Henrich TJ Hu Z Vanichanan J Coakley E Greaves W Gulick RM Kuritzkes DR Tsibris AM 《Journal of virology》2012,86(2):1119-1128
HIV CCR5 antagonists select for env gene mutations that enable virus entry via drug-bound coreceptor. To investigate the mechanisms responsible for viral adaptation to drug-bound coreceptor-mediated entry, we studied viral isolates from three participants who developed CCR5 antagonist resistance during treatment with vicriviroc (VCV), an investigational small-molecule CCR5 antagonist. VCV-sensitive and -resistant viruses were isolated from one HIV subtype C- and two subtype B-infected participants; VCV-resistant isolates had mutations in the V3 loop of gp120 and were cross-resistant to TAK-779, an investigational antagonist, and maraviroc (MVC). All three resistant isolates contained a 306P mutation but had variable mutations elsewhere in the V3 stem. We used a virus-cell β-lactamase (BlaM) fusion assay to determine the entry kinetics of recombinant viruses that incorporated full-length VCV-sensitive and -resistant envelopes. VCV-resistant isolates exhibited delayed entry rates in the absence of drug, relative to pretherapy VCV-sensitive isolates. The addition of drug corrected these delays. These findings were generalizable across target cell types with a range of CD4 and CCR5 surface densities and were observed when either population-derived or clonal envelopes were used to construct recombinant viruses. V3 loop mutations alone were sufficient to restore virus entry in the presence of drug, and the accumulation of V3 mutations during VCV therapy led to progressively higher rates of viral entry. We propose that the restoration of pre-CCR5 antagonist therapy HIV entry kinetics drives the selection of V3 loop mutations and may represent a common mechanism that underlies the emergence of CCR5 antagonist resistance. 相似文献